IBL Healthcare Limited reported a revenue of Rs 4.61 billion and a net profit of Rs 220 million for the year ended June 30, 2026
Filed as: Financial Results for the Year Ended June 30, 2026
Summary
IBL Healthcare Limited reported a revenue of Rs 4.61 billion and a net profit of Rs 220 million for the year ended June 30, 2026, showing growth in both revenue and profit despite some challenges in expenses.
Read the original filingFigures in the filing
| Item | This period | Period before | Change |
|---|---|---|---|
| Revenue | PKR 4.61 billion | PKR 4.32 billion | +6.6% |
| Net Profit | PKR 220 million | PKR 208 million | +5.8% |
| Gross Profit | PKR 1.64 billion | PKR 1.45 billion | +13.7% |
| Cash and Bank Balances | PKR 727 million | PKR 209 million | +247.8% |
| Earnings Per Share (EPS) | PKR 2.24 | PKR 2.11 | +6.2% |
Amounts are in Pakistani rupees as stated in the filing (M = million, B = billion).
What the filing says
- Revenue increased to Rs 4.61 billion, a growth of 6.58% from the previous year.
- Net profit rose to Rs 220 million, marking a 5.78% increase from the prior year.
- Cash and bank balances significantly improved to Rs 727 million, indicating strong cash generation.
IBL HealthCare Limited (IBLHL) on Nafa
Last price Rs 41.00 · Pharmaceuticals · You can own IBLHL shares from your phone.
More IBLHL announcements
- NoticeRevised Presentation of Corporate Briefing Session held on November 02, 2026
- NoticeDissemination Of Video Recording Of Corporate Briefing Session - FY 2026
- NoticePresentation of Corporate Briefing Session 2026
- NoticeTransmission of Quarterly Report for the Period Ended Sep 2026
- NoticeNotice of Corporate Briefing Session
- Financial resultIBL Healthcare Limited reported a stable performance for the quarter ended September 30, 2026Filed as: Financial Results for the Quarter Ended Sep 2026
Source: IBL HealthCare Limited's filing with the Pakistan Stock Exchange. The summary and figures on this page are extracted from the filing by software and can contain errors; the filing itself is the record. This page describes the filing. It is not investment advice and Nafa does not recommend any stock. Investing in securities involves risk, including possible loss of principal.